The Lottery Corporation (ASX: TLC)

How much would you be willing to spend to test your luck? While the cost of a Powerball lottery ticket might not be much—ranging between $6 and $31 (or more, depending on the game type), Aussies collectively spend billions on lottery tickets. However, for consumers, affording the luck of the draw has been paling in

A year on from the demerger from their lotteries business, wagering company Tabcorp (ASX: TAH) has reported $66.5 million in profit thanks to a major digital transformation and favourable regulatory changes that have returned the household brand back to becoming a preferred bookmaker amongst punters.  Demerging from The Lottery Corporation (ASX: TLC) in May 2022

Since the demerger of its lotteries business to concentrate on its wagering business, Tabcorp (ASX: TAH) has made further strides in its restructure with the sale of its eBet business for $62 million, no longer seeing value in its loyalty and tracking systems.  Generating EBITDA of $4.4 million and an EBIT loss of $2 million

When it comes to gambling in Australia, punters have a plethora of service providers to assist them with their bets across lottery, sports, racing or even pokies. Such a lucrative market for providers regularly leads to a battle for market share, one that is changing tides against online lottery company, Jumbo Interactive (ASX: JIN). The

In August 2021, Tabcorp (ASX: TAH) and Jumbo Interactive (ASX: JIN) formalised a long-term extension of their reseller agreement which would enable Jumbo to continue selling lottery tickets online through their OzLotteries platform. Following on from that, Jumbo reported almost 200k new active customers which took their total to 836k with business appearing to be

It may soon be easier for prostate cancer to be diagnosed at an early stage with Telix Pharmaceuticals (ASX: TLX) having submitted their radiopharmaceutical imaging technology to the Food and Drug Administration for approval. The New Drug Application (NDA) comes after completing clinical trials across more than 600 patients which builds on peer-reviewed clinical research